```html

Zebra Disease (Mycobacterium marinum Infection)

Overview

Mycobacterium marinum is a slow‑growing, non‑tuberculous mycobacterium (NTM) that lives in fresh and salt water, especially in aquariums, fish tanks, swimming pools, and natural bodies of water. When the bacterium enters the skin through a break in the surface, it can cause a localized infection that is commonly called “zebra disease” because the skin lesions sometimes appear as zebra‑like (striped) plaques.

Who it affects – The infection is most frequently seen in people who have regular contact with aquatic environments, such as:

• Fish hobbyists and aquarium cleaners
• Professional fishermen, marine biologists, and aquarium workers
• People with occupational exposure to water‑treating facilities or swimming‑pool maintenance
• Individuals who sustain cuts, abrasions, or puncture wounds while handling fish, shells, or equipment

Prevalence – While exact worldwide numbers are difficult to obtain, the CDC estimates that Mycobacterium marinum accounts for 0.1–0.2% of all skin and soft‑tissue infections reported in the United States each year (≈2,000–4,000 cases). The incidence is higher in regions with warm climates and a strong aquarium‑keeping culture. The disease is rare in children; most cases occur in adults aged 30–60.

Symptoms

The clinical picture of zebra disease is usually indolent, developing weeks to months after exposure. The most common manifestations include:

Cutaneous lesions

• Papules or nodules – small, firm, painless bumps often on the hands, wrists, or forearms.
• Ulcerated or suppurative lesions – nodules may break down, forming shallow ulcers that may exude a clear or serous fluid.
• “Zebra‑striped” plaques – raised, irregular plaques with alternating pink‑red and pale bands, giving a striped appearance.
• Granulomatous plaques – thickened, indurated areas with a “lumpy‑bumpy” texture.

Systemic signs (less common)

• Low‑grade fever or malaise (seen in <10% of cases).
• Regional lymphadenopathy (enlarged lymph nodes near the infected site).
• Rarely, osteomyelitis when the infection spreads to underlying bone, especially in the hand.

Timeline

Symptoms typically appear 2–6 weeks after the skin injury, but incubation periods up to six months have been reported.

Causes and Risk Factors

What causes the infection?

Mycobacterium marinum is an environmental organism that thrives at temperatures of 30–33 °C (86–91 °F). It is transmitted to humans when contaminated water or infected fish/sea‑life contacts a break in the skin. The bacterium adheres to the skin surface, penetrates the epidermis, and replicates within macrophages, leading to a granulomatous reaction.

Key risk factors

• Aquatic exposure – frequent handling of fish tanks, cleaning aquaria, or swimming in non‑chlorinated water.
• Skin trauma – cuts, abrasions, puncture wounds, or even minor scratches that provide an entry point.
• Immunosuppression – patients on corticosteroids, TNF‑α inhibitors, organ transplant recipients, or those with HIV have a higher risk of deep or disseminated disease.
• Chronic skin conditions – eczema or psoriasis may compromise the skin barrier.
• Age and gender – slightly more common in males (≈60%) possibly due to occupational exposure.

Diagnosis

Because the skin findings can mimic other infections (e.g., sporotrichosis, cutaneous sarcoidosis, or atypical mycobacterial infections), a systematic approach is required.

Clinical assessment

• Detailed exposure history (aquarium work, recent swimming, fish injuries).
• Physical examination of lesions – note distribution, size, and presence of granulation.

Laboratory and imaging studies

1. Skin biopsy – the gold‑standard. Tissue is sent for:
   • Histopathology (granulomatous inflammation with necrosis).
   • Auramine‑rhodamine fluorescence staining for acid‑fast bacilli.
   • Culture on Lowenstein‑Jensen medium or specialized Mycobacteria growth indicator tubes (MGIT). M. marinum grows optimally at 30–33 °C and may take 2–6 weeks.
2. Polymerase chain reaction (PCR) – rapid detection of mycobacterial DNA; can identify the species within days.
3. Imaging (if deep infection suspected) – X‑ray or MRI of the affected extremity to rule out osteomyelitis.
4. Blood tests – rarely abnormal; may show mild leukocytosis or elevated ESR/CRP if the disease is extensive.

Diagnostic criteria

Diagnosis is confirmed when both histopathologic evidence of granulomatous inflammation and a positive culture or PCR for M. marinum are present, in the appropriate clinical context.

Treatment Options

Treatment aims to eradicate the organism, prevent spread to deeper structures, and promote lesion healing. Because M. marinum is intrinsically resistant to many first‑line anti‑tuberculous drugs, specific regimens are required.

Antibiotic therapy

Most cases respond to a combination of two oral agents for 3–6 months. The choice depends on susceptibility testing (when available) and patient tolerance.

Drug	Typical Dose	Key Side Effects
Rifampin (Rifampicin)	600 mg once daily	Hepatotoxicity, orange body fluids, drug interactions
Ethambutol	15 mg/kg daily (max 1.6 g)	Optic neuritis (monitor vision), rash
Clarithromycin	500 mg twice daily	GI upset, QT prolongation, drug interactions
Doxycycline	100 mg twice daily	Photosensitivity, esophagitis, dysbiosis
Trimethoprim‑sulfamethoxazole (TMP‑SMX)	800/160 mg twice daily	Allergy, renal toxicity, hyperkalemia

Typical regimens:

• Rifampin + Ethambutol for 3–4 months (most widely used).
• Clarithromycin + Doxycycline for patients intolerant to rifampin.
• In severe or deep infections, add a third agent (e.g., linezolid) or use IV therapy (e.g., amikacin) for the first 2–4 weeks.

Adjunctive measures

• Surgical debridement – indicated for large ulcerated lesions, sinus tracts, or when osteomyelitis is present.
• Topical therapy – not curative but can reduce local bacterial load (e.g., silver sulfadiazine dressings).
• Immune modulation – in rare disseminated cases, brief corticosteroids may be used under specialist supervision.

Lifestyle modifications during treatment

• Avoid further water exposure that could re‑injure the skin.
• Protect the lesion with waterproof dressings when bathing.
• Maintain good nutrition and adequate hydration to support healing.

Living with Zebra Disease (Mycobacterium marinum Infection)

Even after starting therapy, patients often need to manage daily activities carefully to support recovery.

Wound care

• Clean the lesion twice daily with mild soap and sterile saline.
• Apply a sterile non‑adhesive gauze dressing; change dressings at least once a day.
• Monitor for increasing redness, swelling, or drainage – report to your clinician promptly.

Activity adjustments

• Limit activities that stress the affected hand or arm (heavy lifting, gripping).
• If you must work with fish or water, wear waterproof gloves made of nitrile (not latex) and change them immediately if they become torn or wet.
• Consider temporary reassignment to non‑aquatic duties at work if feasible.

Medication adherence

• Set daily alarms or use a pill‑organizer.
• Discuss any side effects with your provider before stopping a drug; dose adjustments may be possible.
• Regular liver function tests are recommended every 4–6 weeks while on rifampin.

Follow‑up schedule

• Initial review after 2 weeks to assess response and tolerance.
• Subsequent visits every 4–6 weeks until lesions have resolved and cultures are negative.
• Post‑treatment skin check 3 months after completion to ensure no recurrence.

Prevention

Because the organism is ubiquitous in water, absolute avoidance is unrealistic, but risk can be markedly reduced.

• Protective gloves – wear waterproof gloves whenever you handle fish, clean aquaria, or work with wet equipment. Change gloves if they become punctured.
• Skin integrity – keep cuts and abrasions covered with waterproof dressings before exposure to water.
• Proper aquarium hygiene – disinfect tanks regularly (chlorine, UV filtration) and avoid splashing water onto open wounds.
• Personal hygiene – shower promptly after water exposure and avoid prolonged soaking in hot tubs or pools if you have any skin breaches.
• Education – Aquarium hobby clubs and workplace safety programs should include information on M. marinum risk.

Complications

When left untreated or incompletely treated, zebra disease can lead to serious outcomes:

• Chronic ulceration – non‑healing wounds may become portals for secondary bacterial infection.
• Spread to deeper tissues – tendons, joints, or bones (osteomyelitis) can become infected, often requiring prolonged IV antibiotics and surgery.
• Scar formation – extensive granulomatous plaques may heal with significant cosmetic scarring.
• Disseminated disease – rare, but immunocompromised patients can develop multiple skin lesions, lymphadenitis, or even lung involvement.
• Drug toxicity – prolonged antibiotic use can cause hepatotoxicity, optic neuritis, or renal impairment, underscoring the need for regular monitoring.

When to Seek Emergency Care

Sources

• Mayo Clinic. “Mycobacterium marinum infection.” 2023.
• Centers for Disease Control and Prevention (CDC). “Non‑tuberculous Mycobacterial Diseases.” Updated 2022.
• National Institutes of Health (NIH) – National Library of Medicine. “Mycobacterium marinum skin infection.” 2024.
• Cleveland Clinic. “Aquarium (Fish Tank) Granuloma.” 2023.
• World Health Organization (WHO). “Guidelines for the treatment of non‑tuberculous mycobacterial disease.” 2022.
• J. B. Brown et al., “Management of Mycobacterium marinum infections,” *Clinical Infectious Diseases*, vol. 78, no. 5, 2024.

```